Ruibin Huang

机构：Shantou University, First Affiliated Hospital of Shantou University Medical College, National Taiwan University Hospital, Taipei Medical University · ORCID：0009-0009-8932-1583

发表论文 74 篇 · 总被引 1139 次 · h-index 20

代表论文

• Mn 2+ /CpG Oligodeoxynucleotides Codecorated Black Phosphorus Nanosheet Platform for Enhanced Antitumor Potency in Multimodal Therapy (2024 · ACS Nano · 被引 51)
• Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study (2024 · The Lancet Haematology · 被引 29)
• A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia (2024 · American Journal of Hematology · 被引 16)
• Preoperative CT-derived sarcopenia as a predictor of postoperative complications in patients undergoing laparoscopic radical resection for non-metastatic colorectal cancer: a retrospective study (2025 · International Journal of Colorectal Disease · 被引 9)
• Evaluation of Douyin Short Videos on Mammography in China: Quality and Reliability Analysis (2025 · JMIR Cancer · 被引 8)
• Exosomal miR-146a-5p derived from bone marrow mesenchymal stromal cells regulate Th1/Th2 balance and alleviates immune thrombocytopenia in pregnancy (2024 · Human Cell · 被引 7)